This article explores the current state of pharmaceutical innovation, predicts future trends, and discusses the role of artificial intelligence in shaping the industry. Furthermore, it highlights the ...
Oryzon Genomics, S.A. a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with a strong unmet medical need, today reported financial results for the quar...
These organizations work closely with clinical study sponsors: pharmaceutical, biotechnological and medical device companies, as well as independent researchers and research groups.
Metabolomics has the potential to revolutionize drug discovery by enabling researchers to identify biomarkers, understand disease pathways, and develop personalized treatments tailored to individual p...